Profile data is unavailable for this security.
About the company
PharmaSGP Holding SE is a Germany based company, which operates as a pharmaceutical company. The Company produces and develops non-chemical and over-the-counter drugs and other healthcare products.
- Revenue in EUR (TTM)101.10m
- Net income in EUR16.40m
- Incorporated2020
- Employees89.00
- LocationPharmaSGP Holding SELochhamer Schlag 21GRAEFELFING 82166GermanyDEU
- Phone+49 898 589639150
- Fax+49 898 589639201
- Websitehttps://pharmasgp.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BRAIN Biotech AG | 55.23m | -8.40m | 60.74m | 311.00 | -- | 2.97 | -- | 1.10 | -0.3843 | -0.3843 | 2.53 | 0.9375 | 0.7778 | -- | -- | 167,351.50 | -11.67 | -10.71 | -15.18 | -14.46 | 56.12 | 56.16 | -15.01 | -17.47 | -- | -2.80 | 0.00 | -- | 11.79 | 14.12 | -25.63 | -- | 14.47 | -- |
| Apontis Pharma AG | 36.96m | -11.30m | 70.21m | 177.00 | -- | 2.27 | -- | 1.90 | -1.32 | -1.32 | 4.37 | 3.63 | 0.6302 | 3.09 | 23.11 | 208,835.00 | -19.27 | -- | -22.64 | -- | 62.68 | -- | -30.58 | -- | 2.58 | -- | 0.1659 | -- | -33.67 | -- | -520.38 | -- | -- | -- |
| 4Sc AG | 304.00k | -8.24m | 89.00m | 15.00 | -- | 17.62 | -- | 292.77 | -0.8144 | -0.8144 | 0.0301 | 0.4995 | 0.0236 | -- | 3.68 | 20,266.67 | -63.84 | -39.49 | -77.78 | -42.84 | 68.75 | 92.24 | -2,709.54 | -337.74 | -- | -- | 0.00 | -- | -30.28 | -40.78 | 42.64 | -- | -56.05 | -- |
| Cantourage Group SE | -100.00bn | -100.00bn | 89.06m | 2.00 | -- | 2.01 | -- | -- | -- | -- | -- | 3.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Haemato AG | 260.81m | 9.61m | 90.99m | 78.00 | 9.45 | 0.6068 | 8.45 | 0.3489 | 1.84 | 1.84 | 50.10 | 28.67 | 1.47 | 9.80 | 12.48 | 3,343,690.00 | 5.41 | 2.01 | 6.45 | 2.70 | 7.56 | 8.42 | 3.68 | 1.21 | 1.66 | -- | 0.0203 | 157.20 | -12.95 | -3.03 | 25.39 | 3.32 | -5.75 | -16.74 |
| Heidelberg Pharma AG | 9.05m | -18.28m | 138.88m | 98.00 | -- | 3.08 | -- | 15.34 | -0.3957 | -0.3957 | 0.196 | 0.968 | 0.1222 | 0.2187 | 11.87 | 95,273.69 | -24.68 | -43.91 | -33.18 | -64.34 | 79.75 | 52.13 | -201.94 | -206.24 | 2.22 | -- | 0.104 | -- | -46.75 | 21.87 | -3.27 | -- | -0.8341 | -- |
| PharmaSGP Holding SE | 101.10m | 16.40m | 276.00m | 89.00 | 16.82 | 6.94 | 10.71 | 2.73 | 1.37 | 1.37 | 8.43 | 3.32 | 0.7765 | 1.11 | 11.41 | 1,135,944.00 | 12.59 | 13.70 | 15.39 | 19.98 | 90.64 | 90.20 | 16.22 | 17.56 | 2.14 | 8.97 | 0.6505 | -- | 17.80 | 10.78 | 37.17 | 2.16 | 25.88 | -- |
| Formycon AG | 77.70m | 75.80m | 762.78m | 238.00 | 9.20 | 1.38 | 9.82 | 9.82 | 4.70 | 4.70 | 4.84 | 31.32 | 0.0891 | 104.80 | 3.56 | 326,453.80 | 8.69 | 5.87 | 9.33 | 6.33 | 30.00 | 28.54 | 97.55 | 39.76 | 0.9621 | -0.0189 | 0.0176 | -- | 82.83 | 12.47 | 110.59 | 60.58 | 81.87 | -- |
| Eckert & Ziegler SE | 246.09m | 30.01m | 812.16m | 1.08k | 26.64 | 3.60 | 18.52 | 3.30 | 1.44 | 1.26 | 11.81 | 10.67 | 0.5812 | 3.28 | 5.63 | 228,923.70 | 7.20 | 8.50 | 8.67 | 10.23 | 47.29 | 48.61 | 12.39 | 14.00 | 2.31 | 12.77 | 0.2008 | 35.09 | 10.74 | 7.84 | -2.84 | 13.22 | 33.82 | -30.12 |
Data as of May 06 2024. Currency figures normalised to PharmaSGP Holding SE's reporting currency: Euro EUR
10.06%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Union Investment Privatfonds GmbHas of 02 Jan 2024 | 646.54k | 5.39% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 31 Oct 2023 | 131.86k | 1.10% |
| Mandatum Life Sijoituspalvelut Oyas of 30 Jun 2023 | 94.10k | 0.78% |
| Aktia Varainhoito Oyas of 28 Mar 2024 | 90.00k | 0.75% |
| Fondita Fund Management Co. Ltd.as of 31 Mar 2024 | 61.00k | 0.51% |
| Cr�dit Mutuel Asset Management SAas of 29 Dec 2023 | 60.00k | 0.50% |
| Schroder Investment Management Ltd.as of 31 Jan 2024 | 57.60k | 0.48% |
| Principal Verm�gensverwaltung AGas of 30 Jun 2023 | 36.00k | 0.30% |
| UBS LA MAISON de Gestionas of 30 Dec 2022 | 16.73k | 0.14% |
| KBC Asset Management NVas of 31 Dec 2023 | 13.08k | 0.11% |
More ▼
Data from 30 Jun 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
